课题基金 / 基金详情

Molecular immunological analysis for IgE production and a unique NK cell population producing type 2 cytokine, IL-13

Molecular immunological analysis for IgE production and a unique NK cell population producing type 2 cytokine, IL-13
IgE 产生和产生 2 型细胞因子 IL-13 的独特 NK 细胞群的分子免疫学分析
批准号:
11670468
负责人:
HOSHINO Tomoaki
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HOSHINO Tomoaki的其他基金

相似基金

相关文献

中文摘要
翻译
IL-18已被证明是Th 1 T细胞发育的强辅助因子。然而,我们先前证明,当IL-18与IL-2组合时,在T和NK细胞中存在Th 2细胞因子IL-13的协同诱导(T.Hoshino,J. Immunol.162:5070,1999)。最近,我们和其他小组已经报道IL-18可以在鼠实验模型中潜在地诱导IgE、IgG 1和Th 2细胞因子产生(T.Hoshino,Eur.免疫学杂志30:1998,2000)。在此,我们报道了IL-18转基因(Tg)小鼠的产生,其中表达了与小鼠IG κ链的信号肽融合的小鼠成熟IL-18 cDNA。CD 8 ^+ CD 44 ^<high>T细胞和巨噬细胞增加,B细胞减少,血清IgE、IgG 1、IL-4和IFN-γ水平显著升高。IL-18 Tg小鼠中的脾T细胞产生比对照野生型小鼠更高水平的IFN-γ、IL-4、IL-5和IL-13。因此,体内IL-18的异常表达导致Th 1和Th 2细胞因子的产生增加。
英文摘要
IL-18 has been shown to be a strong co-factor for Th1 T cell development. However, we previously demonstrated that when IL-18 was combined with IL-2, there was a synergistic induction of a Th2 cytokine, IL-13, in both T and NK cells (T.Hoshino, J.Immunol. 162 : 5070, 1999). More recently, we and other groups have reported IL-18 can potentially induce IgE, IgG1 and Th2 cytokine production in murine experimental models (T.Hoshino, Eur. J.Immunol. 30 : 1998, 2000).Here we report on the generation of IL-18 transgenic (Tg) mice in which mouse mature IL-18 cDNA fused to the signal peptide of the mouse Ig κ-chain was expressed. CD8^+ CD44^<high> T cells and macrophages were increased, but B cells were decreased in these mice while serum IgE, IgG1, IL-4 and IFN-γ levels were significantly increased. Splenic T cells in IL-18 Tg mice produced higher levels of IFN-γ, IL-4, IL-5 and IL-13 than control wild type mice. Thus, aberrant expression of IL-18 in vivo results in the increased production of both Th1 and Th2 cytokines.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR, Young HA: "IL-13 production by NK cells : IL-13 producing NK and T cells are present in vivo in the absence of IFN-γ."J.Immunol.. 162. 51-59 (1999)
Hoshino T、Winkler-Pickett RT、Mason AT、Ortaldo JR、Young HA:“NK 细胞产生 IL-13:在缺乏 IFN-γ 的情况下,产生 IL-13 的 NK 和 T 细胞存在于体内。”J.Immunol .. 162. 51-59 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hoshino T,et al.: "IL-13 production by NK cells"J.Immunology. 162. 51-59 (1999)
Hoshino T 等人:“NK 细胞产生 IL-13”J.Immunology。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kim SH, Reznikov LL, Stuyt RJ, Selzman CH, Fantuzzi G, Hoshino T, Young HA, Dinarello CA: "Functional reconstitution and regulation of IL-18 activity by IL-18Rβ chain."J.Immunol.. 166. 148-154 (2001)
Kim SH、Reznikov LL、Stuyt RJ、Selzman CH、Fantuzzi G、Hoshino T、Young HA、Dinarello CA:“IL-18Rβ 链对 IL-18 活性的功能重建和调节。”J.Immunol.. 166. 148- 154(2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hoshino T: "In vivi administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells."Eur.J.Immunol.. 30. 1998-2006 (2000)
Hoshino T:“体内施用 IL-18 可以通过 Th2 细胞因子诱导和 CD4 T 细胞上 CD40 配体 (CD154) 表达的上调来诱导 IgE 产生。”Eur.J.Immunol.. 30. 1998-2006 (2000
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Study for roles of inflammatory cells and cytokines in asthma death, COPD and mouse pulmonary disease models
    • 批准号:
      21590977
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      HOSHINO Tomoaki
    • 依托单位:
    Study for roles of IL-18 in interstitial lung diseases and lung remodeling
    • 批准号:
      15390261
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.19万
    • 财政年份:
      2003
    • 负责人:
      HOSHINO Tomoaki
    • 依托单位:
    Basic Research for Prevention of Interstitial Lung Diseases Induced by IL-18
    • 批准号:
      13670622
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      HOSHINO Tomoaki
    • 依托单位:
    海外基金